Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of YM672 for Painful Bladder Syndrome/Interstitial Cystitis
2005-003367-23Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing YM672 with Placebo (2 arms). Primary endpoint: Global Response Assessment success at Week 12/End of Treatment. Started Nov 2005; status: completed.
02
Drugs
suplatast tosilate
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2005-003367-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003367-23.